Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hartikka

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1988
Development of septal cholinergic neurons in culture: plating density and glial cells modulate effects of NGF on survival, fiber growth, and expression of transmitter-specific enzymesJ Hartikka, F Hefti
Journal of Neuroscience Research|October 1, 1988
Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitroJ Hartikka, F Hefti
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1985
Gangliosides alter morphology and growth of astrocytes and increase the activity of choline acetyltransferase in cultures of dissociated septal cellsF Hefti, J Hartikka, W Frick
Journal of Neural Transmission. Supplementum|January 1, 1995
Cyclic AMP promotes the survival of dopaminergic neurons in vitro and protects them from the toxic effects of MPP+P Hulley, J Hartikka, H Lübbert
Brain Research|February 20, 1984
Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesionsF Hefti, A Dravid, J Hartikka
Journal of Neuroscience Research|June 1, 1992
Cyclic AMP, but not basic FGF, increases the in vitro survival of mesencephalic dopaminergic neurons and protects them from MPP(+)-induced degenerationJ Hartikka, M Staufenbiel, H Lübbert
Neurobiology of Aging|September 1, 1989
Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseasesF Hefti, J Hartikka, B Knusel
Brain Research|December 2, 1985
Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neuronsF Hefti, J Hartikka, M Schlumpf
Brain Research|June 11, 1986
Effect of thyroid hormone analogs on the activity of choline acetyltransferase in cultures of dissociated septal cellsF Hefti, J Hartikka, M B Bolger
Methods in Molecular Medicine|March 5, 2011
Adjuvants for plasmid DNA vaccinesJ Norman, J Hartikka, P Strauch, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1988
Development of septal cholinergic neurons in culture: plating density and glial cells modulate effects of NGF on survival, fiber growth, and expression of transmitter-specific enzymesJ Hartikka, F Hefti
Journal of Neuroscience Research|October 1, 1988
Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitroJ Hartikka, F Hefti
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1985
Gangliosides alter morphology and growth of astrocytes and increase the activity of choline acetyltransferase in cultures of dissociated septal cellsF Hefti, J Hartikka, W Frick
Journal of Neural Transmission. Supplementum|January 1, 1995
Cyclic AMP promotes the survival of dopaminergic neurons in vitro and protects them from the toxic effects of MPP+P Hulley, J Hartikka, H Lübbert
Brain Research|February 20, 1984
Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesionsF Hefti, A Dravid, J Hartikka
Journal of Neuroscience Research|June 1, 1992
Cyclic AMP, but not basic FGF, increases the in vitro survival of mesencephalic dopaminergic neurons and protects them from MPP(+)-induced degenerationJ Hartikka, M Staufenbiel, H Lübbert
Neurobiology of Aging|September 1, 1989
Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseasesF Hefti, J Hartikka, B Knusel
Brain Research|December 2, 1985
Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neuronsF Hefti, J Hartikka, M Schlumpf
Brain Research|June 11, 1986
Effect of thyroid hormone analogs on the activity of choline acetyltransferase in cultures of dissociated septal cellsF Hefti, J Hartikka, M B Bolger
Methods in Molecular Medicine|March 5, 2011
Adjuvants for plasmid DNA vaccinesJ Norman, J Hartikka, P Strauch, et al.
Pageof 3